Systemic Capillary Leak Syndrome With Cerebral Involvement in a


Journal

Neurology. Genetics
ISSN: 2376-7839
Titre abrégé: Neurol Genet
Pays: United States
ID NLM: 101671068

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 06 04 2023
accepted: 08 05 2023
medline: 19 6 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: epublish

Résumé

Systemic capillary leak syndrome (SCLS) is a rare condition associated with episodes of hypotension, hemoconcentration, hypoalbuminemia, and rhabdomyolysis. We describe a middle-aged man presenting with several distinct SCLS-like episodes, the last being fatal. In addition, in the year before the final event, he developed rapid cognitive decline with contrast-enhancing lesions on MRI and highly elevated neurofilament light protein levels in CSF. Data and imaging were obtained from patient medical records. At the time, the SCLS-like episodes were interpreted as myositis secondary to viral infection. A thorough workup for other causes, including genetic testing, was negative. As for the rapid cognitive decline, despite an extensive workup for infectious and inflammatory causes, no definitive diagnosis was made. Whole genome sequencing however identified a The

Identifiants

pubmed: 37334257
doi: 10.1212/NXG.0000000000200081
pii: NXG-2023-000139
pmc: PMC10275405
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e200081

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Déclaration de conflit d'intérêts

The authors report no relevant disclosures. Go to Neurology.org/NG for full disclosures.

Références

Proc Natl Acad Sci U S A. 2022 Sep 6;119(36):e2206327119
pubmed: 36037380
Mult Scler Relat Disord. 2017 Oct;17:1-4
pubmed: 29055436
J Allergy Clin Immunol. 2017 Sep;140(3):663-670
pubmed: 28012935
Nature. 2020 Sep;585(7823):96-101
pubmed: 32814898
Neuron. 2011 Oct 20;72(2):245-56
pubmed: 21944778
J Neurol Neurosurg Psychiatry. 2013 Jan;84(1):79-87
pubmed: 23085936
Nat Rev Neurol. 2018 Sep;14(9):544-558
pubmed: 30120348
Neurology. 1999 Jul 13;53(1):220-2
pubmed: 10408566
Int J Mol Sci. 2021 Jun 29;22(13):
pubmed: 34209673
Front Cell Neurosci. 2021 May 05;15:661447
pubmed: 34025358
Neurol Sci. 2021 May;42(5):2095-2098
pubmed: 33411202
Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e301
pubmed: 27844039
Science. 2016 Mar 18;351(6279):1324-9
pubmed: 26989253

Auteurs

Stefan Sennfält (S)

From the Department of Clinical Neuroscience (S.S., T.G., F.P.), Karolinska Institutet; Department of Neurology (S.S., F.P.); Department of Pathology and Cancer Diagnostics (O.A.), Karolinska University Hospital; Department of Oncology-Pathology (O.A.); Department of Molecular Medicine and Surgery (M.E.), Karolinska Institutet; Center for Inherited Metabolic Diseases (M.E.); and Department of Neuroradiology (T.G.), Karolinska University Hospital, Stockholm, Sweden.

Oskar Aspegren (O)

From the Department of Clinical Neuroscience (S.S., T.G., F.P.), Karolinska Institutet; Department of Neurology (S.S., F.P.); Department of Pathology and Cancer Diagnostics (O.A.), Karolinska University Hospital; Department of Oncology-Pathology (O.A.); Department of Molecular Medicine and Surgery (M.E.), Karolinska Institutet; Center for Inherited Metabolic Diseases (M.E.); and Department of Neuroradiology (T.G.), Karolinska University Hospital, Stockholm, Sweden.

Martin Engvall (M)

From the Department of Clinical Neuroscience (S.S., T.G., F.P.), Karolinska Institutet; Department of Neurology (S.S., F.P.); Department of Pathology and Cancer Diagnostics (O.A.), Karolinska University Hospital; Department of Oncology-Pathology (O.A.); Department of Molecular Medicine and Surgery (M.E.), Karolinska Institutet; Center for Inherited Metabolic Diseases (M.E.); and Department of Neuroradiology (T.G.), Karolinska University Hospital, Stockholm, Sweden.

Tobias Granberg (T)

From the Department of Clinical Neuroscience (S.S., T.G., F.P.), Karolinska Institutet; Department of Neurology (S.S., F.P.); Department of Pathology and Cancer Diagnostics (O.A.), Karolinska University Hospital; Department of Oncology-Pathology (O.A.); Department of Molecular Medicine and Surgery (M.E.), Karolinska Institutet; Center for Inherited Metabolic Diseases (M.E.); and Department of Neuroradiology (T.G.), Karolinska University Hospital, Stockholm, Sweden.

Fredrik Piehl (F)

From the Department of Clinical Neuroscience (S.S., T.G., F.P.), Karolinska Institutet; Department of Neurology (S.S., F.P.); Department of Pathology and Cancer Diagnostics (O.A.), Karolinska University Hospital; Department of Oncology-Pathology (O.A.); Department of Molecular Medicine and Surgery (M.E.), Karolinska Institutet; Center for Inherited Metabolic Diseases (M.E.); and Department of Neuroradiology (T.G.), Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH